These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3569410)

  • 1. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ; Wreggett KA; Seeman P
    J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
    Mulder TB; Grol CJ; Dijkstra D; Horn AS
    Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
    List SJ; Seeman P
    J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cations on high-affinity binding of 3H-ADTN to dopaminergic sites in calf caudate tissue.
    Lamont JS; Kula NS; Baldessarini RJ
    Neuropharmacology; 1987 Jun; 26(6):637-9. PubMed ID: 3601010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
    Schoemaker H
    Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of high-affinity binding of [3H](+/-)2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) to bovine caudate nucleus tissue.
    Arana GW; Baldessarini RJ; Lamont JS; Amlicke D; Neumeyer JL
    Biochem Pharmacol; 1983 Oct; 32(19):2873-80. PubMed ID: 6626260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
    Closse A; Frick W; Markstein R; Maurer R; Nordmann R
    J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M; Totaro JA
    Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J; De Vries JB; Tepper PG; Krause DN; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Mar; 147(2):249-58. PubMed ID: 3130270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ; Costall B; Naylor RJ
    J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.
    Osborne NN
    Cell Mol Neurobiol; 1981 Jun; 1(2):167-74. PubMed ID: 7346167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.